Globe Biomedical Takes the Stage at the International Myopia Congress 2024

By The Blink Team

The 19th International Myopia Congress (IMC) brought together over 1,000 researchers, clinicians, and innovators from more than 50 countries on the tropical shores of Sanya, Hainan Island, China, from September 25 to 28, 2024. With more than 400 research posters and 80 presentations covering the cutting edge of myopia science, IMC is the definitive forum for new ideas in pediatric eye health — and this year, Globe Biomedical had a seat at the table.

Dr. Jonathan Li of UCSF presented our research poster to a global audience of myopia specialists, sharing real-world validation data from Blink Frames. The presentation highlighted the device's ability to objectively monitor the key behavioral risk factors for myopia progression — outdoor time, screen time, and frame wear compliance — using a suite of specialized sensors embedded within a pair of ordinary-looking glasses.

Data graphs from the Blink Frames validation study, presented at the International Myopia Congress 2024, showing sensor accuracy for outdoor time and wear-time detection — Figure 1: Validation data from the Blink Frames poster, presented at IMC 2024 in Sanya, China. Results demonstrate sensor accuracy across real-world indoor and outdoor environments.

The Numbers Speak for Themselves

At the heart of the poster were the results of rigorous, real-world validation testing. Blink Frames demonstrated:

>93% accuracy in outdoor time detection
>96% accuracy in frame wear-time monitoring
Reliable spectral differentiation between indoor artificial light and true outdoor illuminance

These are not lab conditions. This is sensor data collected in the real world — a critical distinction for clinicians who need to trust the tools they recommend to patients and families.

Why This Matters: From Guesswork to Clinical Evidence

For decades, clinicians advising families on myopia prevention have had to rely on one profoundly unreliable tool: the parent questionnaire. As research has consistently shown, self-reported outdoor time and screen time data is notoriously inaccurate. Children over-report outdoor play; parents lose track of screen time. The result is that the most effective behavioral intervention for myopia — increasing time spent outdoors — has never had a reliable way to be prescribed, monitored, or verified.

Blink Frames changes that equation entirely. By continuously monitoring behavioral risk factors through discreet, eye-facing sensors, we give clinicians an objective, evidence-based view of a child's daily environment — the kind of data that turns a lifestyle recommendation into a measurable clinical tool.

An Idea Whose Time Has Come

Presenting at IMC is more than a milestone — it is a signal that the global myopia community is ready for this conversation. The evidence base is building. The clinical community is paying attention. And with Blink Frames now validated in real-world environments and FDA-registered for myopia and amblyopia monitoring use, we are positioned to bring objective, continuous ocular risk factor monitoring to clinics around the world.

We are grateful to Dr. Jonathan Li and the entire UCSF collaboration team for championing this work on the international stage. The future of myopia management is data-driven — and we are proud to be writing those first chapters.